Regarding CLBP, comment in the AGM livestream by the prof was "We will update with feedback we receive from the FDA with regards to pathway for the next programme' or something along those lines.
Still a little cagey and a suspiciously limited amount of information. Other indications they have given a guide on the meeting eg 'constructive meeting' - however in this instance, they have said nothing. My view on this is that the news is bad and they'll release in a near term update with hopefully more positive news, to offset any impact on the share price.
Hopefully i'm wrong.
Regarding CLBP, comment in the AGM livestream by the prof was...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |